AC Immune is a startup based in France, most recent round Series-c-plus, 2 tracked investors.
AC Immune is a company founded in 2003 headquartered in France. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
AC Immune is a clinical-stage biopharmaceutical company discovering, designing and developing therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases with a focus on Alzheimer's disease.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.